Kim Walpole

Head of Trials.ai, ZS Associates · 1 appearance on the record.

computed by AI from the episodes · how this works → · full disclaimer →

founderexecutiveoperatorLinkedIn ↗trials.ai ↗

Kim Walpole co-founded Trials.ai, an AI-powered platform designed to optimize clinical trial protocols and study design, inspired by losing her best friend to terminal pancreatic cancer. In 2023, the startup was acquired by global management consulting and technology firm ZS Associates to integrate its AI solutions into clinical development workflows.

10statements → 6claims → 0claims resolved → 3.9/5average certainty → 1.2/5average debate potential →

6 not checkable as stated how the 6 claims stand · each chip opens the sources

6 assertions · 4 disclosures · every statement was checked. The predictions and assertions are the 6 claims: statements the public record can support or contradict. 0 are resolved, and 6 name no date, number or outcome precise enough to check. Everything else (opinions, insights, what ifs, disclosures) can never be settled by the record, so it carries no assessment.

The record, in short

What the tape says about how Kim argues and how the claims held up. Everything they said, and everything said about them, is in the tabs below.

How they sound: not measured why? →

We measure speaking style by listening to the audio itself, and a fair number needs at least 2,000 words from one person on tape we have measured. There is too little of Kim Walpole on measured tape to publish a rate. This says nothing about how they speak.

What they said10 Episodes1

Everything Kim Walpole said on Top Founders that made the record, most notable first. Filter by type, assessment or year in the ledger →

Assertion Not checkable as stated

Walpole: Trials.ai cuts study design time from 9–12 months to weeks

“On the study design side, you know, it takes anywhere from nine to 12 months to do that. We're cutting that down to weeks and eventually days.”

Kim Walpole Mar 1, 2019 ▶ 4:01 1315 Her Best Friend Died From Terminal Cancer, She Launches MedTech SaaS Raising $2.5m on $10m Pre

Disclosure

Kim Walpole: Trials.ai in fundraising talks at $10M pre-money valuation

“We're conversations we're having is at a ten million pre.”

Kim Walpole Mar 1, 2019 ▶ 8:58 1315 Her Best Friend Died From Terminal Cancer, She Launches MedTech SaaS Raising $2.5m on $10m Pre

Disclosure

Walpole: Average phase two trial generates about $200K annually for Trials.ai

“For us, an average trial, maybe a phase two trial of 350 users would generate about 200 K on average annually.”

Kim Walpole Mar 1, 2019 ▶ 5:40 1315 Her Best Friend Died From Terminal Cancer, She Launches MedTech SaaS Raising $2.5m on $10m Pre

Disclosure

Walpole: Trials.ai raised $750k in December and is raising $2.5M

“And we raised 750,000 back in the end of December, and now we're doing a 2.5 million dollar raise.”

Kim Walpole Mar 1, 2019 ▶ 7:48 1315 Her Best Friend Died From Terminal Cancer, She Launches MedTech SaaS Raising $2.5m on $10m Pre

Assertion Not checkable as stated

Kim Walpole: Trials.ai generates about $25,000 MRR

“Currently we're at about 25 K MRR.”

Kim Walpole Mar 1, 2019 ▶ 9:06 1315 Her Best Friend Died From Terminal Cancer, She Launches MedTech SaaS Raising $2.5m on $10m Pre

Assertion Not checkable as stated

Kim Walpole: Trials.ai closed $250,000 in new bookings over two months

“Over the last two months you know, we've closed about 250,000 in new bookings.”

Kim Walpole Mar 1, 2019 ▶ 10:51 1315 Her Best Friend Died From Terminal Cancer, She Launches MedTech SaaS Raising $2.5m on $10m Pre

Assertion Not checkable as stated

Walpole: Trials.ai cut a customer's data errors by 20%

“We've got one customer that came to us, they ran their first trial, they liked it so much, we saved them three hours on admin tasks per day, per person And then decrease their data errors by 20%.”

Kim Walpole Mar 1, 2019 ▶ 11:20 1315 Her Best Friend Died From Terminal Cancer, She Launches MedTech SaaS Raising $2.5m on $10m Pre

Assertion Not checkable as stated

Walpole: Trials.ai has experienced zero paying customer churn

“No, we haven't lost anyone yet.”

Kim Walpole Mar 1, 2019 ▶ 11:56 1315 Her Best Friend Died From Terminal Cancer, She Launches MedTech SaaS Raising $2.5m on $10m Pre

Disclosure

Walpole: Trials.ai trained algorithms on historical trial data and medical journals

“So we are, you know, we started by training our algorithms on historic data from trials that were both successful as well as not successful, medical journals, basically anything we could get our hands on.”

Kim Walpole Mar 1, 2019 ▶ 2:13 1315 Her Best Friend Died From Terminal Cancer, She Launches MedTech SaaS Raising $2.5m on $10m Pre

Assertion Not checkable as stated

Kim Walpole: Trials.ai works with 4 customers across 5 studies

“We actually have two trials that are completed. We're working with four customers. We've got five studies total. And like I said, we've got seven coming up. We're rolling one out right now.”

Kim Walpole Mar 1, 2019 ▶ 10:23 1315 Her Best Friend Died From Terminal Cancer, She Launches MedTech SaaS Raising $2.5m on $10m Pre

Appearances (1)

Episode	Date	Speaking time
1315 Her Best Friend Died From Terminal Cancer, She Launches MedTech SaaS Raising $2.5m on	Mar 1, 2019	8m

Kim Walpole

The record, in short

How they sound: not measured why? →

Appearances (1)

Turn any episode into a week of clips.